Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Burke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pediatrics|February 4, 2003
Adolescent participation in tobacco promotions: the role of psychosocial factorsAlison Burke Albers, Lois Biener
American Journal of Public Health|February 26, 2015
Flavored alcoholic beverage use, risky drinking behaviors, and adverse outcomes among underage drinkers: results from the ABRAND StudyAlison Burke Albers, Michael Siegel, Rebecca L Ramirez, et al.
American Journal of Preventive Medicine|December 21, 2012
Minimum financial outlays for purchasing alcohol brands in the U.SAlison Burke Albers, William DeJong, Timothy S Naimi, et al.
NEJM Evidence|February 6, 2024
Threats to BlindingO M Davies, Katherine S Takvorian, Daniel Muller, et al.
NEJM Evidence|February 27, 2024
How Treatment Effect Heterogeneity WorksC Corey Hardin, Michael Fralick, Daniel Muller, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pediatrics|February 4, 2003
Adolescent participation in tobacco promotions: the role of psychosocial factorsAlison Burke Albers, Lois Biener
American Journal of Public Health|February 26, 2015
Flavored alcoholic beverage use, risky drinking behaviors, and adverse outcomes among underage drinkers: results from the ABRAND StudyAlison Burke Albers, Michael Siegel, Rebecca L Ramirez, et al.
American Journal of Preventive Medicine|December 21, 2012
Minimum financial outlays for purchasing alcohol brands in the U.SAlison Burke Albers, William DeJong, Timothy S Naimi, et al.
NEJM Evidence|February 6, 2024
Threats to BlindingO M Davies, Katherine S Takvorian, Daniel Muller, et al.
NEJM Evidence|February 27, 2024
How Treatment Effect Heterogeneity WorksC Corey Hardin, Michael Fralick, Daniel Muller, et al.
Pageof 1